FDA Weighs Pros And Cons Of Off-Label Promotion
On Nov. 9 and 10, 2016, the U.S. Food and Drug Administration conducted a public meeting on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products." The FDA's notice...To view the full article, register now.
Already a subscriber? Click here to view full article